PRICE T ROWE ASSOCIATES INC /MD/ - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 30 filers reported holding EXAGEN INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EXAGEN INC
ValueSharesWeighting
Q4 2019$12,132,000
+56.6%
477,630
-4.5%
0.00%
+100.0%
Q3 2019$7,745,000500,0000.00%
Other shareholders
EXAGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 854,042$2,049,7010.86%
PERKINS CAPITAL MANAGEMENT INC 252,405$6060.64%
COWEN AND COMPANY, LLC 966,022$2,318,4520.24%
Penbrook Management LLC 74,010$177,6240.15%
RTW INVESTMENTS, LP 1,364,336$3,274,4060.07%
PLATINUM INVESTMENT MANAGEMENT LTD 264,130$633,9120.02%
Nantahala Capital Management 146,559$351,7420.02%
WASATCH ADVISORS LP 1,000,561$2,401,3460.02%
First Bank & Trust 21,954$530.02%
SILVERCREST ASSET MANAGEMENT GROUP LLC 502,615$1,206,2760.01%
View complete list of EXAGEN INC shareholders